MedTrace Logo

Biomarkers During Pregnancy

NCT04108455 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2023-05-06

No results posted yet for this study

Summary

This study aims to obtain preliminary data for utility of alternate biomarkers for monitoring glucose control in diabetic women during pregnancy and/or predicting risk of adverse neonatal events in these women.

Conditions

  • Diabetes Mellitus in Pregnancy
  • Gestational Diabetes

Interventions

OTHER

Specimens Collected

Serum will be collected from patients at multiple times during pregnancy for later analysis.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Ebony Carter, MD · Washington University School of Medicine

Eligibility

Min Age
14 Years
Max Age
48 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-15
Primary Completion
2021-11-01
Completion
2023-11-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04108455 on ClinicalTrials.gov